A prospective trial comparing a silicone elastomer intravenous cannula (Visis) with a polytetrafluoroethylene cannula (Cathlon).
Post-infusion phlebitis remains one of the most frequent causes of hospital morbidity with an incidence varying between 13 and 39 per cent (1-4). A recent study indicated that a silicone elastomer cannula (Visis) had desirable properties (5). We have carried out a prospective trial comparing the value of such a cannula with a Teflon cannula (Cathlon) already in routine use.
D002404:Catheterization / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D005440:Fluid Therapy / Q000009:adverse effects / Q000295:instrumentation*; D006801:Humans; D007263:Infusions, Parenteral / Q000009:adverse effects / Q000295:instrumentation*; D010689:Phlebitis / Q000209:etiology; D011138:Polytetrafluoroethylene / Q000009:adverse effects*; D011446:Prospective Studies; D012826:Silicone Elastomers / Q000009:adverse effects*
D012826:Silicone Elastomers; D011138:Polytetrafluoroethylene